International Expansion Biopharma Group is actively expanding in Europe with planned Arad, Romania facility investments and multi-regional operations (UK, France, Ireland, USA), presenting cross-border sales opportunities for equipment, CDMO services, and full formulation development capabilities.

Integrated CDMO Offerings The company combines equipment provision with specialist CDMO services for liquid formulations and lyophilized products, enabling a one-stop solution for customers seeking feasibility studies through GMP/non-GMP contract manufacturing, which can be positioned to win larger outsourcing deals.

R&D to Production With capabilities spanning R&D formulation, cycle development, process reviews, lyo lab analysis, and manufacturing, Biopharma Group can target biotech startups and pharma players looking to accelerate from development to market-ready products.

High-Value Asset Investment Recent capital commitments of up to approximately $97M for a new pharmaceutical factory in Romania signal strong growth and potential for enterprise-level equipment orders, facility services, and long-term collaboration opportunities.

Quality and Reach Recognized for industry-leading expertise and quality across pharma, diagnostics, and biotech, Biopharma Group’s established regional divisions and global reference base create credibility for scalable partnerships, multi-site deployments, and risk-managed outsourcing deals.